DEF 14A

Company

Hepion Pharmaceuticals, Inc.

Filed

December 15, 2015

Period of Report

February 4, 2016

Accession Number

0001104659-15-084716

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →